Trends in the global R&D pipeline suggest that the pharmaceutical industry is navigating a landscape of competing factors. Though new pharmaceuticals are moving to market faster than ever, developers need time to optimize formulation for the sensitive, high-potency active ingredients that dominate the current pipeline of drug candidates.
The challenge of balancing speed and thorough development can be solved by choosing hard-shell capsules as a dosage form. Manufacturers can dose small amounts of pure active pharmaceutical ingredients (APIs) or simple blends directly into hard capsules. Learn how micro doses less than 5 mg or low doses, which can range from 5 mg to 100 mg, delivered in hard capsules are an accessible solution that enables manufacturers to bring new medicines from R&D to market more quickly.
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy